September 2019

September 2019

Welcome to the September issue where our cover feature explores the microbes living in and on our bodies – and what they mean for drug discovery. Upfront asks: can gender bias skew preclinical results? And could a mosaic-based vaccine offer at-risk people more choice when it comes to HIV prevention? Sue Springett highlights the importance of health and safety in the lab, in In My View; and in Business, we speak with Ron Kander and Parviz Shamlou about Jefferson’s Institute for Bioprocessing, and Maeve Magner explains how digital solutions can improve the supply chains of emerging economies. Finally, we Sit Down With Joan Mannick, Co-Founder and Chief Medical Officer at resTORbio, Massachusetts, USA.

Recent Issues